Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MHAA4549A in an Influenza A human challenge model
2013-001983-52Phase 2Completed
- Sponsor
- Genentech
- Start
- Sep 2013
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Influenza A infection comparing MHAA4549A with Placebo (2 arms). Primary endpoint: Viral AUC of nasopharyngeal viral load by qPCR. Started Sep 2013; status: completed.
02
Drugs
vedolizumab
03
Conditions
Influenza A infection
Beyond the preview
Go deeper on 2013-001983-52.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001983-52.